Because it has been difficult to identify and separate malignant cells in human lymphoid malignancies, we have developed a flow cytometry-based fluorescent in situ hybridization (FISH) technique using immunoglobulin (Ig) heavy chain variable region (V H) gene probes. After obtaining the specific V H gene sequence expressed by the multiple myeloma IM-9 cell line and the malignant cells in five multiple myeloma patients, sense and antisense biotinylated single-stranded RNA probes were prepared by transcription from the malignant clone's V H DNA sequences. The cells from the IM-9 cell line and from the mononuclear bone marrow cells of multiple myeloma patients were fixed, hybridized with the above biotinylated RNA probes, incubated with streptavidin-phycoerythrin, and analyzed by FACS' analysis. The myeloma cells stained positive with their own specific antisense V H biotinylated RNA probes, whereas sense and irrelevant antisense biotinylated probes demonstrated only background staining. Dilutional concentrations of the IM-9 cell line with normal bone marrow cells were also accurately quantitated by this procedure. The application of this technique will allow a more accurate assessment of tumor burden in patients with multiple myeloma and should permit an accurate method of tumor cell purification for clinical as well as biological studies. Furthermore, this technological advance should be equally effective at identifying specific V H gene-expressing cells in other lymphoid malignancies, as well as in nonmalignant B cell disorders. (J. Clin. Invest. 1995. 95:964-972.)
Introduction
The expression of genes in a clonal population of cells has been previously defined and quantitated by Northem blot and polymerase chain reaction (PCR) analysis (1) (2) (3) (8, 9) . Furthermore, this unique sequence does not vary with time over the course of the disease. Consequently, this gene may serve as a marker for identifying all malignant cells in this clonal B cell malignancy (8-1O) . In these malignant cells, the most specific region of the Ig gene sequence resides in the VH segment. Since this VH gene sequence is both specific and sensitive for the tumor cells in MM, we attempted to develop a FISH flow cytometric technique using biotinylated antisense probes to the expressed VH gene as a means of identifying and separating malignant cells in this B cell tumor.
Methods
Myeloma cell line characteristics. IM-9, an IgG K secreting human multiple myeloma cell line (American Type Culture Collection, Rockville, MD) (11) , was grown in RPMI 1640 (Irvine Scientific, Santa Ana, CA) with 10% fetal bovine serum and supplemented with 2 mM L-glutamine.
Patient material. Bone marrow cells were obtained from five patients with IgG-producing MM and from one normal donor after informed consent and approval from our Human Subjects Protection Committee. The heparinized sample was layered over Histopaque 1077 (Sigma Immunochemicals, St. Louis, MO) centrifuged at 400 g for 30 min, and the mononuclear layer was obtained and washed three times in PBS after red blood cell (RBC) lysis with RBC lysis buffer (Sigma Immunochemicals).
VH gene determination. Total RNA was extracted using the guanidine isothiocyanate method ( 12) VH1   5' CCA TGG ACT GGA CCT GGA GG 3'  VH2  5' ATG GAC ATA CTT TGT TCC AC 3'   VH3   5' CCA TGG AGT TTG GGC TGA GC 3'   VH4  5' ATG AAA CAC CTG TGG TTC TT 3'  VHS   5' ATG GGG TCA ACC GCC ATC CT 3'   VH6   5' ATG TCT GTC TCC TTC CTC AT 3'  Cy   5 GCC CCC AGA GGT GCT CTT GGA GGA GG 3' IM-9 CDR2 sense 5' GGA GTG GGTCGC AGG TAT 3' IM-9 CDR2 antisense 5' AGT TGT CTC TGG AGA TGG 3' WAD#35 CDR2 sense 5' AGT GGG TCT CAA GTA TTA C 3' WAD#35 CDR2
5' TGT TGT TCT GGA TAT GGT G 3' antisense C-y (Table I) (13) . To visualize the PCR products, 10 Al of the PCR product was electrophoresed through a 1.5% agarose gel stained with ethidium bromide and examined under ultraviolet light.
To purify the PCR product, the remainder of the PCR reaction was electrophoresed through a 1.5% low melt agarose gel, and the appropriately sized band was excised. A centrifuge filter unit (Spin-X; Costar Corp., Cambridge, MA) was used to extract the DNA from the agarose. The PCR fragment was then cloned directly into the Srfl site of the PCRScript SK(+) vector To test whether a shorter RNA probe could improve assay specificity and efficiency, shorter PCR fragments were prepared for the IM-9 cell line and for MM patient WAD#35. Individual specific primers were synthesized (Operon Technologies, Inc., Alameda, CA) complementary to regions in the complementarity determining region 2 (CDR2), which were highly specific for the myeloma sequence after comparison with other germline VH gene sequences (14, 15) (Fig. 1) . 50 pmol of each primer was added to 1 isg of total RNA obtained from the IM-9 cell line or myeloma patient WAD#35 bone marrow cells, and the PCR product was synthesized using the procedure described above. A shorter 89-bp PCR product was obtained from these cells using the IM-9 cell CDR2 specific primers while a shorter 87-bp PCR product was made for MM patient WAD#35 using the patient CDR2 specific primers. These shorter PCR fragments were cloned into the Srf I cut PCR-Script 
130 sense primer DP-31 TGCACTGGGT CCGGCAAGCT CCAGGGAAGG GCCTGGAGTG GGTCTCAGGT
240 250 Figure 1 . Sequence comparison of the IM-9 cell line and WAD#35's myeloma VH genes with the most homologous germline gene for both which was VH3 DP-31 (15) (dashes indicate identity, underlines indicate the CDR regions, and arrows indicate the primers used to amplify the short CDR2 region probe). Sequences were obtained after cDNA amplification of BM RNA using VH family ( 13) and Cy oligonucleotide probes. vector using the above procedure. A plasmid containing the long or short PCR fragment would then be used as a template in the preparation of the RNA probe as outlined below.
RNA biotinylated probe preparation. All single-stranded RNA probes were prepared by transcription from the synthesized plasmid DNA. The plasmid DNA was linearized with either BamHI or NotI. Next, sense or antisense RNA transcripts were generated with either T3 or T7 DNA-dependent RNA polymerase using the Transcription In Vitro Systems kit (Promega Corp.). Biotin-labeled probes were prepared by substituting biotin-l 1 UTP (Enzo Biochem Inc., New York) or digoxigenin-1 1-UTP (Boehringer Mannheim Biochemicals, Indianapolis, IN) in the transcription reactions. Each probe had a near equivalent "U" content in its sense and antisense orientation. After performing the in vitro transcription reaction, RQ1 RNase-free DNase (Promega Corp.) was added to digest the DNA template for 15 min at 37°C. The probe was resuspended in diethylpyrocarbonate (DEPC)-treated water and was visualized after denaturing gel electrophoresis before purification by passage through a Sephadex G-50 Quick Spin Column for RNA (Boehringer Mannheim Biochemicals). The RNA probe concentration was determined by the method described by Ravichandran (5).
A 0.1 -ILg aliquot of the RNA sense and antisense probes was treated by adding 10 gg/ml RNase at 37°C for 15 min as a control experiment to determine whether an intact RNA probe was necessary for hybridization specificity. All of the probes were incubated with 1% DEPC at 37°C for an additional 15 min before use.
Cellfixation. The fixation and hybridization conditions were adapted from Bauman et al. (4) . All solutions were made with DEPC-treated water, and all reagents and equipment were kept free of RNase. The cells were washed twice in a buffer containing 1 x Hank's balanced salt solution and 20 mM Hepes, pH 7.2 (HH buffer). After washing, all further steps were carried out in 1.5-ml microfuge tubes. The cells were resuspended at 15 x 106 cells/0.5 ml HH and fixed by the addition of an equal volume of freshly prepared 2% formalin in HH. After incubation for 5 min at room temperature, the cells were spun at 300 g for 5 min, washed once with HH, and resuspended in 0.3 ml HH. To this solution, 0.7 ml of absolute ethanol was added, and the cells were then stored at -20°C until use. Care was taken to avoid cell clumping by repeated and gentle pipetting of cells. After the fixation procedure, samples could be stored at -20°C for several months without affecting assay performance.
In situ hybridization. Typically, an aliquot containing the 3-5 x 105 fixed cells in a 1.5-ml microfuge tube was treated with 1 ptl of 10% DEPC in ethanol per 50 Ml of cell suspension for 15 min at room temperature to block the activity of endogenous RNase. The cells were then centrifuged at 300 g and incubated with 0.5% Tween 20 (Tables I and II) . The PCR product ranged in size from 414 to 486 bp and included the entire VH gene (Table  II) , and was then sequenced and compared with published VH genes (14, 15) . The cloned myeloma VH sequence was then used to make sense and antisense RNA probes for in situ hybridization. A pair of specific sense and antisense primers around the CDR2 region ( Fig. 1) was then designed and used to amplify and subclone the myeloma Ig CDR2 regions of IM-9 and MM patient WAD#35. Shorter 89-and 87-bp RNA probes, respectively, were obtained after translation of these subclones for the further studies of in situ hybridization.
Identification of IM-9 cells with an antisense RNA probe. To define the optimal conditions for detection of VH expression by means of FISH and flow cytometry (FISH-FC), the initial The fluorescent histogram profile of the IM-9 cell line hybridized with the biotinylated RNA probes is shown in Fig. 2 . When the specific antisense RNA probe was used for hybridization, a very strong signal was obtained which averaged approximately 124-fold higher than the sense probe control value. Increased signal above background staining was detected on all of the IM-9 cells using the antisense probe.
To prove that intact RNA probes are required for generating the higher signal, the IM-9 sense and antisense probes were treated with RNase, and the products were hybridized with the IM-9 cells (Fig. 3) (Fig. 6 ). This improvement may also be due to increased efficiency of RNA probe cell entry because of the smaller size of the shorter RNA probe. Both the IM-9 cell line and the myeloma cells from patient WAD#35 express Ig derived from the same VH gene family (VH3). Consequently, their VH gene sequences are quite similar although there is only 80% homology within the region encompassed by the CDR2 probes (Fig. 1) . To assay for RNA probe gene specificity, both CDR2 antisense probes derived from the IM-9 and WAD#35 myeloma cells, respectively, were hybridized with the IM-9 cells. It was found that the irrelevant WAD#35 antisense RNA probe showed an approximate 19-fold lower signal than the matching IM-9 antisense RNA probe (Fig.  7) . This illustrates that the detection of VH gene expression is specific even for different members of the same VH family.
Probe sensitivity. To test the ability of FISH-FC to quantitate the percentage of cells that express a particular VH gene in a mixed heterogeneous cell population, known numbers of IM-9 cells were mixed with normal donor's BM mononuclear cells by serial dilution. Eight samples containing IM-9 cells at various percentages (100, 75, 50, 25, 10, 5, 2, and 1%) were analyzed using the IM-9 VH CDR2 antisense probe in addition to a control sample containing only normal BM cells. The pure cell populations were used to define the cursor position that best differenti- ated between a positive and a negative cell, and this was set at the location where 99% of IM-9 cells would have higher fluorescence intensity staining than the normal BM cells. When these samples were analyzed, the calculated percent contamination of the eight samples by FISH-FC was 99, 73.6, 48.6, 24.3, 10.2, 4.9, 2.0, and 1.1% (Fig. 8) . In every case, there was an easily identified population of cells with significantly higher fluorescence staining presumably representing the cells from the IM-9 cell line. Therefore, this FISH-FC technique can effectively identify the target cells which express a particular VH gene in mixed populations with a high degree of accuracy.
Discussion
It is important to be able to specifically identify and separate malignant cells in mixed populations in human lymphoid malignancies for basic research and clinical applications. Previously developed approaches of studying gene expression will not permit further purification of the malignant cells due to (a) cell disruption (Northern blot and colony blot assays), or (b) cell fixation to slides (FISH) (16) (17) (18) The VI, genie segment includes the first and second complementarity deterni-in iing region.s and three franmework regions. The CDRs encode for the regions of the Ig protein which confer antigen binding specificity and display considerable hypervariability compared with the surrounding framework regions which are usually more conserved within each VF, family ( 19) . Therefore, sequences containing the CDR2 were used as templates to synthesize biotinylated RNA transcripts to improve specificity of the antisense probes. We have sequenced the Ig gene produced by myeloma cells from 48 patients and found that the CDRs contain the highest degree of somatic mutation (averaging 14. 1 % ) after comparison with germline VH genes (8 lengths of the CDR2-derived templates are -80-90 bp, which has been shown to be the optimal length for RNA probes used for fluorescent in situ hybridization (4) . It is possible that probes to the CDR3 of the heavy chain sequence would be even more specific since this is the region of greatest Ig sequence diversity. However, we did not choose the CDR3 region as a probe in our study primarily because its length is too short for optimal PCR and RNA transcription. This inherent problem was demonstrated by the fact that the fluorescent signal with the CDR3 probe was markedly weaker than that of the CDR2 probe when compared in our lab using the IM-9 cell line (data not shown). To overcome the difficulty in using the shorter CDR3 probe, it may be possible to extend the length of the probe into the framework regions. However, because of the more conserved nucleotide sequences, this may compromise probe specificity. In addition, we have found a lack of N region insertions in the VH-D and D-JH junctions and the CDR3 length to be short (average length 30 bp) in myeloma (20) . As a result, this region is less optimal than CDR2 in developing antisense probes in myeloma. The abolition of hybridization signal by RNase treatment suggests the formation of RNA/RNA hybrids between the antisense biotinylated RNA probe and the mRNA within these myeloma cells. This observation is similar to other reports using non-Ig antisense RNA probes (4) . These prior studies and our observations suggest that the detection of fluorescent signal is dependent upon the formation of a complex involving both the target mRNA and the antisense probe.
Although we do not have direct evidence as to whether clonal cells with suboptimal Ig production would remain detectable with FISH-FC, in theory only a few Ig mRNA molecules should be detectable by this assay assuming 100% hybridization efficiency (21) . When the IM-9 cell line was used, the majority of these cells expressed fluorescence intensity above the highest I FISH-FC technique. Detection of IL-1 expression in different murine tissue samples and human monocytes has been accomplished with hybridization using 32P-or 35S-labeled cDNA probes (27, 28) . Past attempts to quantitate oncogene in situ expression specifically in myeloma cells have involved determination of c-myc expression by in situ hybridization procedures with a 35S-labeled c-myc antisense probe on morphologically identified myeloma plasma cells (29) . These previous attempts to use in situ hybridization procedures in cytokine and/or oncogene expression studies have been limited by the inability to precisely identify the malignant cells and by the requirement of cell fixation on the slides.
In summary, the FISH and FC method should allow the precise identification and separation of clonal B cells in a mixed cell population. This technical advance will be important in further characterizing the specific phenotype and genotype of cells in both malignant and nonmalignant clonal B cell disorders. Moreover, this technique should also be applicable to nonlymphoid cells in which the identity of a specific cell population can be ascertained by the expression of a unique gene.
